33 assets in Pancreatic Neuroendocrine Tumor

Therapeutic assets addressing Pancreatic Neuroendocrine Tumor, rated under Floatz methodology v0.2 and sorted by current rating.

Asset	Sponsor	Phase	Rating
Oxodotreotide Pancreatic Neuroendocrine Tumor	University of Chicago	P4	BBB (75)
Everolimus Pancreatic Neuroendocrine Tumor	Exelixis	P4	BBB (72)
Irinotecan Pancreatic Neuroendocrine Tumor	M.D. Anderson Cancer Center	P2/3	BB (70)
L-Cysteinamide, D-Phenylalanyl-L-Cysteinyl-L-Phenylalanyl-D-Tryptophyl-L-Lysyl-L-Threonyl-N-(2-Hydroxy-1-(Hydroxymethyl)Propyl)-, Cyclic (2->7)-Disulfide, (R-(R,R))- Pancreatic Neuroendocrine Tumor	RayzeBio, Inc.	P3	BB (68)
Capecitabine Pancreatic Neuroendocrine Tumor	Gustave Roussy, Cancer Campus, Grand Paris	P3	BB (66)
Zanzalintinib Pancreatic Neuroendocrine Tumor	Exelixis	P3	BB (66)
Abiraterone Pancreatic Neuroendocrine Tumor	Exelixis	P3	B (60)
Atezolizumab Pancreatic Neuroendocrine Tumor	Exelixis	P3	B (60)
Enzalutamide Pancreatic Neuroendocrine Tumor	Exelixis	P3	B (60)
Lanreotide Pancreatic Neuroendocrine Tumor	RayzeBio, Inc.	P3	B (60)
Nivolumab Pancreatic Neuroendocrine Tumor	Exelixis	P3	B (60)
Prednisone Pancreatic Neuroendocrine Tumor	Exelixis	P3	B (60)
Edotreotide Pancreatic Neuroendocrine Tumor	ITM Solucin GmbH	P2	B (57)
Abemaciclib Pancreatic Neuroendocrine Tumor	University of Washington	P2	CCC (53)
Belzutifan Pancreatic Neuroendocrine Tumor	Merck Sharp & Dohme LLC	P2	CCC (53)
esk981 Pancreatic Neuroendocrine Tumor	University of Michigan Rogel Cancer Center	P2	CCC (53)
Foslinanib Pancreatic Neuroendocrine Tumor	TaiRx, Inc.	P2	CCC (53)
Lurbinectedin Pancreatic Neuroendocrine Tumor	National Cancer Center, Korea	P2	CCC (53)
Nab-Sirolimus Pancreatic Neuroendocrine Tumor	Aadi Bioscience, Inc.	P2	CCC (53)
Pantoprazole Pancreatic Neuroendocrine Tumor	Washington University School of Medicine	P2	CCC (53)
Sandostatin Pancreatic Neuroendocrine Tumor	CSPC ZhongQi Pharmaceutical Technology Co., Ltd.	P2	CCC (53)
Surufatinib Pancreatic Neuroendocrine Tumor	Changhai Hospital	P2	CCC (53)
Syhx2008 Pancreatic Neuroendocrine Tumor	CSPC ZhongQi Pharmaceutical Technology Co., Ltd.	P2	CCC (53)
Fulvestrant Pancreatic Neuroendocrine Tumor	University of Chicago	P1	CC (43)
ryz401 Pancreatic Neuroendocrine Tumor	RayzeBio, Inc.	P1	CC (43)
Autologous Anti-Cd19 Car-Expressing T Lymphocytes Pancreatic Neuroendocrine Tumor	Anusha Kalbasi	P1	CC (41)
Cyclophosphamide Pancreatic Neuroendocrine Tumor	Anusha Kalbasi	P1	CC (41)
Fludarabine Pancreatic Neuroendocrine Tumor	Anusha Kalbasi	P1	CC (41)
Fludeoxyglucose Pancreatic Neuroendocrine Tumor	Anusha Kalbasi	P1	CC (41)
il13ralpha2-specific hinge-optimized 4-1bb-co-stimulatory car/truncated cd19-expressing autologous tn/mem cells Pancreatic Neuroendocrine Tumor	Anusha Kalbasi	P1	CC (41)
[212pb] vmt-α-net Pancreatic Neuroendocrine Tumor	David Bushnell	Early P1	C (39)
Mrna-0523-L001 Pancreatic Neuroendocrine Tumor	Shanghai Jiao Tong University School of Medicine	N/A	D (30)
Cabozantinib Pancreatic Neuroendocrine Tumor	Exelixis	P3	NR ()